GPC4 and metabolic dysfunction-associated steatotic liver disease: The adipokine glypican-4 (GPC-4) is a cell surface proteoglycan that has been associated with increasing obesity, diabetes mellitus, metabolic syndrome, bone development and non-alcoholic fatty liver disease (NAFLD) in previous studies1–5.